The safety of plasma-derived products in Australia

被引：0

作者：

Guirguis, Andrew ^{[1
]}

Wood, Erica

机构：

[1] Australian Red Cross Blood Serv, Melbourne, Vic, Australia

来源：

AUSTRALIAN PRESCRIBER | 2010年 / 33卷 / 03期

关键词：

coagulation; intravenous immunoglobulin; pathogen inactivation;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Plasma-derived products are used in Australia in a wide variety of clinical settings. The majority of these products are manufactured locally from voluntary blood donations. The preparation of plasma products is subject to rigorous safety measures, including screening blood donors, testing plasma for infectious material, and subjecting plasma to dedicated pathogen inactivation steps. The safe use of plasma derivatives requires correct storage and handling.

引用

页码：76 / 79

页数：4

共 9 条

[1]

*AUSTR RED CROSS B, TRANSF MED MAN

[2]

*AUSTR RED CROSS B, TRANSF TRANSM INF FA

[3] Warfarin reversal: consensus guidelines on behalf of the Australasian Society of Thrombosis and Haemostasis [J].

Baker, RI ;

Coughlin, PB ;

Gallus, AS ;

Harper, PL ;

Salem, HH .

MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (09) :492-+

[4]

*CSL BIOTH, 2010, OPT QUAL PATH SAF PU

[5]

Finfer S, 2004, NEW ENGL J MED, V350, P2247

[6]

*VICT GOV HLTH INF, 322008 VICT GOV HLTH

[7]

2006, BLOODSAFE PROGRA AUG

[8]

2007, AUSTR HLTH MIN C DEC

[9]

REV AUSTR PLASMA FRA

← 1 →